Coverage
-
August 25, 2014
Fresenius Kabi USA LLC has lost its bid to show that Actavis Inc. and India-based Dr. Reddy's Laboratories Ltd. infringed four of Fresenius' patents by attempting to market a generic form of the sedative and anesthetic Diprivan, according to a trial opinion filed Monday in Delaware federal court.
1 other articles on this case.
View all »